|
MEDTRONIC, INC. ACHIEVE ADVANCE MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECT
|
Back to Search Results |
|
| Model Number |
2ACH15 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Non specific EKG/ECG Changes (1817); Tachycardia (2095); Cramp(s) /Muscle Spasm(s) (4521)
|
| Date of Event |
07/23/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that during a pulmonary vein isolation procedure using the catheter afapro23 afa pro 23, the patient experienced st segment elevation after the first cryo ablation in the left inferior pulmonary vein.Freeze parameters were normal at -63 degrees for 180 seconds, and the onset of st segment elevation occurred 2 minutes and 45 seconds into the freeze.Interventional cardiology was contacted, and 10mg intravenous vasodilator medication was administered.The procedure was aborted under general anesthesia.Coronary angiography revealed completed occlusion of the right coronary artery and chronic coronary artery disease in the left main/left anterior descending arteries.The patient exhibited small runs of ventricular tachycardia and premature ventricular contractions, which were treated with 150mg of an antiarrhythmic medication.An interventionalist injected 300mcg intracoronary vasodilator medication into the aortic root/right coronary artery, which immediately resolved the st segment elevation.The event was diagnosed as acute coronary spasm.The patient was stable, transferred to the intensive care unit for medical management, and underwent a computed tomography surgery consult.No further patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id: afapro23 (24079) product type: balloon catheter product id: 4fc12 (0012741791) product type: sheath product id: nitron (n2412a0113) product type: console medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|